$1.55
-0.0200 (-1.27%)
At Close: Jun 02, 2026
Covalon CFO Danny Brannagan To Step Down In January 2022
12:08pm, Friday, 24'th Dec 2021 Business Insider Markets
(RTTNews) - Covalon Technologies Ltd. (CVALF) said that its Chief Financial Officer Danny Brannagan will be stepping down in January 2022 to pursue other endeavours. The company plans to appoint an interim Chief Financial Officer while it undertakes a search for a new Chief Financial Officer. Covalon Technologies is a researcher, developer,
Financial Review: UpHealth (NYSE:UPH) and Covalon Technologies (OTCMKTS:CVALF)
07:16am, Monday, 20'th Dec 2021 Dakota Financial News
UpHealth (NYSE:UPH) and Covalon Technologies (OTCMKTS:CVALF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations and price targets for UpHealth and Covalon []
Short Interest in Covalon Technologies Ltd. (OTCMKTS:CVALF) Increases By 462.5%
07:16pm, Monday, 13'th Dec 2021 Transcript Daily
Covalon Technologies Ltd. (OTCMKTS:CVALF) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 9,000 shares, a growth of 462.5% from the November 15th total of 1,600 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is […]
Covalon Technologies (CVALF) CEO Brian Pedlar on Q4 2021 Results - Earnings Call Transcript
05:49pm, Monday, 13'th Dec 2021 Seeking AlphaCovalon Technologies (CVALF) CEO Brian Pedlar on Q4 2021 Results - Earnings Call Transcript
12:49pm, Monday, 13'th Dec 2021
Covalon Technologies (CVALF) CEO Brian Pedlar on Q4 2021 Results - Earnings Call Transcript
Covalon Technologies (COV) Scheduled to Post Earnings on Monday
01:40pm, Friday, 10'th Dec 2021 Transcript Daily
Covalon Technologies (CVE:COV) is scheduled to be issuing its quarterly earnings data before the market opens on Monday, December 13th. Shares of CVE COV opened at C$2.55 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.42 and a debt-to-equity ratio of 217.37. Covalon Technologies has a 12 month low […]
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2021 Financial Results
05:41pm, Wednesday, 08'th Dec 2021
MISSISSAUGA, ON, Dec. 8, 2021 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year
Covalon Technologies (OTCMKTS:CVALF) versus Sema4 (NASDAQ:SMFR) Financial Contrast
07:12am, Tuesday, 07'th Dec 2021 Dakota Financial News
Covalon Technologies (OTCMKTS:CVALF) and Sema4 (NASDAQ:SMFR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Institutional and Insider Ownership 74.1% of Sema4 shares are owned by institutional investors. Strong institutional ownership []
Covalon Technologies to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
05:10pm, Friday, 03'rd Dec 2021
MISSISSAUGA, ON / ACCESSWIRE / December 3, 2021 / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will
Covalon Announces Retirement of Board Member
08:00am, Friday, 24'th Sep 2021
MISSISSAUGA, ON, Sept. 24, 2021 /PRNewswire/ - Covalon Technologies Ltd.
Covalon Technologies (CVALF) CEO, Brian Pedlar on Q3 2021 Results - Earnings Call Transcript
11:43am, Monday, 30'th Aug 2021
Covalon Technologies (CVALF) CEO, Brian Pedlar on Q3 2021 Results - Earnings Call Transcript
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2021 Financial Results
03:49pm, Thursday, 26'th Aug 2021
MISSISSAUGA, ON, Aug. 26, 2021 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 20
Sign In
Buy CVALF